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Among 11 isoforms of protein kinase C (PKC) , we 
previously reported that the 1] isoform ofPKC plays a 
crucial role in mediating differentiation of keratino-
cytes. Activation of PKC is associated with its intra-
cellular translocation from the cytoplasm to the 
plasma membrane, followed by down-regulation 
through proteolytic cleavage of the PKC molecules. 
In the present study, we demonstrated that the 1] 
isoform ofPKC is unique in that it is not translocated 
nor down-regulated upon stimulation. The level of 
the 1] isoform, assayed by immunoblotting, remained 
unchanged during the first 12 h and then increased 
slightly up to 24 h when treated with tumor promot-
ers or activators of PKC in constitutively expressing 
normal human keratinocytes. The activity of the 1] 
P rotein kinase C (PICC ) is a serine/threonin e protein kinase w hose activity is rcgulated by interactions with head groups of membrane lipids. PKC has a cru cial role in signal transduction elicitcd by various extraccllular stimuli . Molecular cloning revealed that PKC exists as a 
family of isoforl1lS with re la ted struc tures and activation mecha-
nisms. E leven m embers of the PICC family have been identified to 
date and can be classified into three major groups (reviewed in [1]) : 
Group A, phosphatidylserin e (PS)-, diacylglycerol (DG)-, and 
Ca2 +-depcndent conventional PKC (ex, {31, (3U, and 'I isoforms); 
Group B, Ca2 ·t- -independent novel PKC (8, E, T) , 0, and /-L); and 
G roup C, Ca2 + - and DG-independent atypical PKC ( ~ and AIL). 
PICC is transiently activated by DG tb at is produced in the 
membrane by the signal-indu ced turnover of inositol phospholipids 
[2] . T umor-promoting phorbol esters sucb as 12- 0 -tctradccanoyl-
phorbo l-13-acetate (TPA) substitute for DG and persistently acti-
vate PKC [3] . T h e activation of PKC is accompanied by a 
direction al in trace llular translocation from the cytoplasm to the 
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isoform also remained unchanged after the 12-0-
tetradecanoyl-phorbol-13-acetate treatment, as 
judged by binding to an ATP analog, autophosphor-
ylation, and phosphorylation of an exogenous sub-
strate. The a isoform of PKC, however, was rapidly 
down-regulated and was undetectable by 6 h after the 
treatment. These observations were further con-
firmed by immunohistochemical staining of normal 
human l{eratinocytes and transiently expressing 
COS1 cells. In addition, although the a isoform 
rapidly translocated to the plasma membrane, the 1] 
isoform remained in the cytoplasm. KeJ' Ivol,ds: c1wles-
te 1'0 l s IIlfatel12 -0 - tetm decal/oJ' I-pll 0r/)O/-13 -aceta tel tel eoci-
di,,111Iezel'eill. ] Illvest Del'llwtol 106:790-794, 1996 
plasm a membrane [4] . and subsequ ently down-regu\;lted [5- 9] . 
Down-regulation of PKC is caused by the proteolytic cleavage of 
the molecules [7-9]. 
We have clon ed the T) isoform ofPICC fi'om a mouse skin cDNA 
library [lO]. Lt has been shown to ha ve unique tissue disuibution , 
localiz in g in va rio us epithelia l ti ssucs such as skin , tongue, esoph-
agus, stomach, intestine, trachea , and bronchus [11]. The transcript 
of T) iso fonn is most abundant in skin. 10 times more than that 
found in brain tissLle [1.1 J. T hese epithelial tissLles express also the ll'. 
8, and ~ isoform s which are members of th e PKC family that are 
ubiquitously distributed in tissues [1 2]. III s ;11I hybridization and 
immunohistoch emical sta ining demonstrated that the T) isoform is 
localized in the diffe rcntiating cells o f 110rmal and diseased skill 
[11 ,13J. In th e previolls study [14) , we repm:ted tbat the T) isoform 
is activated by cholesterol sulfate, w hich is a metabolite of choles-
terol formed during squamo us differentiation (1 5]. Furthermore. 
tbe T) isoform i s localized on the rough endoplasmic rcticulum [1 61-
[n this study, we exa mined the alte rations of levels of the T) and 
a isofofms by immunoblotting and immulJofluorescen ce staining of 
constitutively expressing normal human keratinocytes and tran-
sientl y expressing COSl cells. [n contrast to the ex iso form , the 7) 
isofo rm w as neither down-regulated nor translocated , keeping the 
kinasc activity after TPA trea tm ent. 
MATER.lALS AND METH ODS 
Chemicals C holesterol sulfatc . 5' -p-AlI orosu lfoll)'lbclI zoyl .. dcnosine 
(FS13A) and mye lin basic protein (M13P) wcre purchasl!d from Sigma (St. 
Loui s. MO ). TPA and I1lcze rein wcre obta ined li.·o", LC Laborato ri es 
(Woburn. MA) . slI - l.2-Dioctanoylglycc rol (DiC8) was purchased from 
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Avanti 'Polar-Lipids (Alabaster, AL). Tclcocidin was" gift from Or. H. 
Fujiki (Sait",,,a Cancer Center, Saitama, Japan). 
Antibodies Polyeional anti-1') isoform antibodies were raised in rabb its 
against synthetic pep tides of 01, 0 2/03, and 0 4 regions, containing the 
amino acid sequences Q"TSTKQKTNKPTYNEEFC", pJ I3GN ISPT_ 
SKLISRSTLRRQGKEJJ.I, and 16M'NQOEFRNFSYYSPELQL',M3, respec-
tively [1 6]. Polyeiona l anti-e, isoform antibody (anti-CTa) was raised 
against a synthetic peptide (064"QSOFEGFSYVN PQFVHPrLQSA y 672) at 
the C- terminal region of the a isoform [1 7]. Anti-FSBA antibody was 
purchased from Boehringer Mannheim (Postf:lch . German y). 
Cell Culture and ONA Transfection Normal human keratinocytes 
were isolated from pieces of skin and grown in MCDB 153 supplemented 
with 10 ng/ml epidermal growth f.1ctor, 0.5 /Lg/ml hydrocortisone, 
5 /Lg/ml insulin , 0.1 /LM phosphorylethano lamine, 10 /Lg / ml transferrin , 
and 60 /Lg/ml bo vine pituitary extract (l 8,19). Monkey kidney COS '! ce lls 
were cultured and transfected as reported elsewhere [1 0,20]. 
Irnntunoblotting Proteins extracted from the ce ll s were applied to 
sodium dodec)'1 sulfa te-po lyacrylamide gel e lectrophoresis (SOS-PAGE) 
and imrnunoblotting by using the anti-1')-D2/D3 antibody and the anti- a 
isoform antibody at concentration of1-5 /Lg/ml. Samples fro m 1 to 2 X 105 
cells were loaded on each lane to allow d irect comparison of nPKC1') and 
cPKCex contents . T he antibody- specific bands wcre visualized by thc 
HClP/ NBT phosphatase substratc system (Kikegaard & Perry Laboratories, 
Gai thersburg, MD) and quanti tated by using a densitometer. 
FSBA-Labeling, A utophosphorylatiol1 , and Protcin Kinase Assay 
The 1') isoform was preparcd fiorn cultured hUlllan keratinocytes as prev i-
ously describcd (14). BrieAy, after trcat111cnt w ith T PA, the cells were 
solubilized ill silll w ith 'I'Y" Triton Xl00 in the extraction bu ffe r consisting of 
20 mM T ris-HC I (pH 7.5), 5 111M cthylencglyco l-bis(f3-aminoethyl ether)-
N,N,N' ,N' ,-tctraacetic acid, 5 111M 2-mcrcaptoethanol , and 0.5 mM phc-
nyhncthylsul fonyl Auoridc. T he extract was applied to a DE52 (Wha tman, 
Majdstone, England) co lumn and washed with thc extraction buffe r. The 1') 
isoform was clu tcd as a single ft'a ctio ll wi th 200 rnM NaCI (14). 
For FSBA labeling, the enzylllc fraction was dial yzed agai nst the buffcr of 
50 mM N-2-hydroxylethylpipcraz ine-N' -2-cthan esul fu nic acid (pH 7.5) 
and 0.5 mM phenylmethylsulfonyl RU O\'ide to remove reducing agent and 
free amines that rcact with FS.BA. T he enz)' lll e was labeled w ith FSJ3A ill a 
50 - /L1 reaction mix ture consisting of 50 111M N-2-hydroxylethylpipcrazine-
N' - 2-ethanesulfo nic acid (pH 7.5), 1 IllM FSJ3A, 0.2 mg/llli MBP, in the 
presence or absence of 64 /LM PS and '160 nM T PA at 30°C for 10 IIlill. T he 
labeled 1) isoform was illlIllulloprecipi tated w ith the 'l11ti-1') (DI, D2 / D3, 
and 04 peptides) antibody mixture ( 14). fo llowed by SDS-PAGE and 
immuno blotting w ith an ti-FSIJA antibody. 
For autop hosphorylation and protein ki nase assay, the 1') isoforlll was 
partiall y purifi ed usi ng a DE52 co lullln and immunopreci pita ted with the 
ano-T} a n tibody rnixturc and protein A in th e extrac ti o n butler w it ho u t 
2-mercap toethanol at 4°C. An aliquot of the enzyme-imlllunocomplex was 
incubated in an au tophosphoryla t io n-rcactio n l11i xturc consistin g of 20 InM 
Tns-HCI (pH 7.5), 11'-·12 PIAT P (0.37 MBq. 222 TJ3q/ mlllol) , 5 111M 
MgS04 , 1 111M ethylencglycol-bis({3-alllinoethyl cther)-N,N,N' ,N' -tct-
raacetic acid, 64 /LM PS, and 160 11M TPA at 30°C for 10 min 'Ind subjected 
to SDS-PAGE and au toradiograph y. T hc cnzYllle-illl111unocomplex was also 
subjected to prote in kinase assa), by using MJ3P as a substrate of the 
phospho-group accepto r as prev io usly described (14) . 
itnD'lunofinoresccncc Staining T he ccll s grown on covcrsli ps were 
fixed with 4% fo rmaldehyde ill phosphatc-bu{/:c red sa line (containing 8.0 g 
of NaCI, 0.2 g of KCl, 0.2 g of KH 2PO., and 1.1 5 g of Na2 HPO •. 2H 20 
per liter) for 30 min. and thcn penneabilized with methanol for 10 min. 
After blocking with 3% goat serulll in phosphate-buffe red sa li nc fo r 30 min , 
the cells we re incubatcd with thc anti-1')- IYI antibody or anti-u isofonn 
antibody at 1-5 /Lg/ lTIl in 1 % goa t serlim-phospha te-blllfered sa line for I h. 
followed by incubation with the second antibody, flu oresccin iso thiocya-
nate- conjuga ted anti-rabb it IgG, fo r I h. 1l11mllnoR uo rcscence was observed 
under a Auorcscencc microscope (Olympus, Tokyo. J apan) and a confoca l 
laser scanning microscope (Molecular Dynamics. SUlln yva le, CAl. 
R ESULTS 
Absence of Down-Regulation of the T) Isoform Upon Stim-
ulation T h e le vels of express io n of th e 11 and a iso fo rms of PKC 
were examined by immunoblotting of pro te ins of n ormal human 
keratin ocytes treated with 160 nM TPA. As shown ill Fig lA and 
B, the 11 an d a isoform s w ere found as a sing le band w ith M, 
80,000. When th c in tcnsity of bands was q u anti fied densitometri-
caUy (Fig lC), the levcls of 11 isoform were found to remain 
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F ig ure 1. Immulloblots of the Tj isoforul (A ) and the a isoform (B). 
and their densitomctric quantification (C). (A, B) L nll i" 1, for 0 11; Inllo 
2, 3 h ; Inlll' J . 6 h ; 1m Ie 4, 12 h; Inll<: 5, 24 h aftcr thc trcatment of normal 
human kcratinocytes with 160 nM TPA . A '1'01IJS indicate SOk]) PKC 
isofonns. (C) Densito metric quan tifIcation ofimmunoblots of the 1') isoform 
(e) and the ex isofonn (0 ). For thc 1') isofor111, mcan ::!: SEM (hnr) of three 
independen t cxpcritTI cnts a.rc sh own . T h e c ur ve of th e aisofonll waS based 
o n a singlc experiment, although down-regulation at 6 h aftcr the treatmcnt 
was repeated ly confirmed. Relative PKC lcvels (arbi trary un its) ofthc band 
at 0 h are dcfin ed as 100. 
con stant at the con trollcvel during the first 1 2 h and th e n il1creased 
slig h tly up to 24 h . T h e .. bsence of d own-regulation was a lso 
o b served at a high e r (1 600 nM) or a lower (16 nM) concen tration 
of TPA (Fig 2) . In con trast, t h e a isoform rapidly dccreased aftcr 
th e TPA treatment, fa lling to app roximately 25% of the contro l 
levels at 3 h , 21yo at 6 h , and was n ot detectable the reafter (Fig 1) . 
Oth c r tumor prom oters and activato rs of PKC were used to 
examine their e ffects on the regulation of PKC. As summarized in 
Table I , t h e levc l of 11 isoform in normal human kera tin ocytes dId 
not ch ange after 6 h of tumor p ro m otin g and PKC -activatab.le 
m ezercin or te leocidin treatm ent. As fo r the a isofonn, m ezcre m 
and te lcocidin ca used rap id down-reguJation . A synthetic OG, 
DiCS, h owever , did n ot down-regulate the Icvel of the a isofo rm . 
We h ave previously rcported th at ch o lestero l sulfate is a speCIfic 
activator for th e 'T/ isoform (1 4) . W he n treated w i th 102 J.LM 
cho lesterol sulfa te, the leve ls of th e 1') isofor111 wcre not chan gcd 
sig nifIcantl y at 6 h (Table I) and at 24 h (data n o t shown). The a 
isoform was also not down-regulated b y cholesterol sul f:, tc .. T h e 
pare nta l cho lestc ro l a t 129 J.LM did not ca use an)' appreCIabl e 
ch an ge in thc 11 and a isoform s. 
T he differc nces in the regu lation of a and 1') isoform were fur th e.r 
demonstrated by immuno flu orescen ce staining of cells (Fig 3). 
When trea te d with 160 nM TPA, the antibody- specifi c sign al of the 
11 isoform was no t ch an ged fo r 12 h in bOtll the cons ti tu tive ly 
expressing norm al human k era tinocytcs ,uld thc transicn tly express-
in g COS l cell s. U nde r th e " lin e condition s, the sig n als of th e a 
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Figure 2 . Absence of down-regulation of the 'Y/ isoform for the 
treatment of human keratinocytes with TPA for 6 h at 16, 160, and 
1600 nM. Amounts of the 1) isofo rm was quantitated as shown in Fig 1. 
isofoml in COSl cells were considerably reduced at 3 h post-TPA 
treatment, and no detectable signals were obtain ed for tim es greater 
than 6 h post treatment. 
Kinase Activity of the 11 Isoform After TP A Exposure 
Protein kinase activity of the 'YJ isofonn was examined by the 
following three assays after the TPA treatment of human 'keratino-
cytes (Fig 4). First, we used FSBA, a stereochemical analog of A TP 
that has been shown to specifically bind to the ATP-binding site of 
a wide r;mge of enzym.es including protein kinases (21) . Covalent 
binding of FSBA is stable and can be detected by immul1oreaction 
with anti-FSBA antibody (22). Fig 4A shows tbe specificity of 
'FSBA binding to the 71 isoform: labeling ofFSBA was dependent on 
the PKC activators, i.e., TPA and PS (Fig 4A, Innes 1-4), but was 
inhibited in the presence of excess amount of ATP and Mg2+ (Fig 
4A, Im1e 5) . When normal keratillocytes were treated with TPA 
(Fig 4B) , the FSBA-Iabeled 71 isoform remained at the nOlltreated 
level for the first 12 h and increased at 24 h, in keeping with the 
immunoblotting on the 17 isoform (Fig 1). 
Activity of the 'YJ isoform after TPA treatm ent was further 
examined by autophosphorylation and phosphorylation of MEP, a 
good substrate of the 17 isoform (14) . As shown in Fig 4C, 
autophosphorylation of the immunoprecipitated 1] isoform was 
almost constant for 12 h after TPA treatment and increased at 24 h . 
PhosphOl)'lation of MBP also showed a similar time course after the 
TPA treatment, remaining at a similar level for 24 h (Fig 4D) . 
Under these conditions, the immunocomplex of 71 iso fonn was 
Table I. Down-Regulation of the 'l'/ and a Isoforms of 
PKC in Response to Tumor Promoters and 
Activators of PKC 
Concentration 
Chemical (fLM) 
TPA 0.16 
Mezerein 0.15 
TcIeocidin 0.22 
DiC8 290 
C holesterol sulfate 102 
C holesterol 129 
Relative Level (Arbitrary 
Unit)" 
'1 isoform a isoform 
87 :!:: 15" 2 :!:: 2" 
82 18 
81 0 
94 101 
77 85 
109 95 
,/ Values were ohlained by densilometry of irnmunoblots ofchc Q' and fl i .~oforms in 
human keratinocytcs .~t:imulaLCd with tumOr promoters <! nd ;:Jcd vOIto rs for 6 h . Values 
;lrC relativ e to 0 h. which were set to " value o f 1 00. 
/> Mean :t SEM of three independent experiments (Fig 1). while the rest arc based 
on a single cxperin'lent. 
THE J OURNAL OF INVESTIGATI VE DERMATOLOG). 
Figure 3. Immunofluorescence staining of the T) isoform (A-F) an<\. 
the (Y isoform (G-1) in normal human keratillocytes (A- C) and ~ 
transiently expressing cost cells (D-I) . The ce lls were treated wi~ 
160 11M TPA for 0 h (A,D,C), 3 h (H) , 6 h (B,t,!), and 12 h (C,F), foUowc~ 
by inllnunoAuoresccll cc staining . 
found to autophosphorylate and phosphorylate MBP il1dependentl~, 
of PS and TPA (data not shown) , probably due to activation by tll~ 
antibody binding. 
These results indicate that th.e T) isoform remained its prote~ 
kinase activity after long exposure to TPA. 
Absence of Translocation of the "Y/ Isoform Upon Stimula\ 
tion Using a confocal lase r scanning microscope, the intraceJ]ul~ 
localization of the two isofonns was examined after treatment wit~ 
TPA. As shown in Fig SA, immunofluorescence of the T) isofol'l1\ 
was detected in the cytoplasm, mainly at the nuclea r periphery o\' 
normal human keratinocytes, confirming our previous observatiol\ 
that the 71 isoform is localized 011 the rough endoplasmic reticulun\ 
(16) . Five min after treatment with TPA, the signal of the T) isofortl\ 
remained at the perinuclear space (Fig SB). The same localizati 
of the 71 isofonn was obtained with transiently overexpressin~ 
COSl cells (Fig 5C,D). In contrast , the inlmunofluorescence ofth~ 
(l' isoform was rapidly translocated from the cytoplasm to th~ 
plasma membrane within 5 min after the TPA treatment of th~ 
overexpressing COSl cells (Fig 5E,F) . 
DISCUSSION 
In this study, we demonstrated that the 'YJ isoform ofPKC was 110 \ 
down-regulated nor translocated when stimulated by tumor pro-
moters or activators ofPKC. In contrast, the a isoform was rapid!) 
translocated from the cytoplasm to the plasma membrane an 
down- regulated. The absence of down- regulation o f the 1] isofonn 
is consistent with our previous report that normal hum an kerari· 
nocytes are resistant for down-regulation of specific binding sites 0: 
a phorbol ester [23]. 
Fournier and Murray [24] reported that topica l application ' 
TPA to mouse skin ill, tl illO ca used rapid and sustained dOl 
regulation of PKC for 3-4 days after the treatment. Although th 
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Figure 4 . Protein kinase ac tivity of the .,., isoform, assayed b y FSBA 
labeling (A, B), a utophosphorylation (C) and phosphory lation of 
MBP (D). (A) Specificity ofFSDA labeling. T he 1'/ isoform was labe led with 
1 roM FSEA in the presence of nonl! (/nll e 1) . 63 f.LM PS (/tl lI l! 2). '160 nM 
TPA (/nlle 3), PS and TPA (/tlIIC 4) , or PS, TPA. I mM MgC I2 and 20 111M 
ATP (/nlle 5). T he labeled 1'/ protein was il11l11unoprecipi tatcd with the anti-1'/ 
an ribody m ix ture. fo llowed by immunoblotting with anti-FSBA amibody. 
Arrows indicate 80kD 1'/ isofonn (A-C). (B) Time course of the FSEA 
labeling after treatrn en t with 160 nM TPA for 0 h (lnlll' 1). 3 h (/nllc 2), G h 
(Jalle 3), 12 h (lilli e 4). and 24 h (lnll e 5). Protein extract of 5 X '10' cells was 
applied to each lane. (C) Autophosphoryl"tion of the 1'/ isola,.,n after the 
TPA treatment. T he lanes correspond to those of B. T he inllllunoprecipi-
ta ted 1'/ isoform from T PA-treated keratinocytcs was incubated in the 
presence of[y_J2Pj ATP. subjected to SOS-PAGE and autoradiography. (D) 
Phosph o rylatio n of MllP. T he inll1l1H10prcci pi tatcd 17 isofonl1 fr0 111 the 
TPA-treated kcratinocytes was incubated in rhe presence of MDl' as a 
substrate and [y_02 p]AT P. Vcrl;rn /lill l'. ,u P-Cercnkov coun t of phosphory-
lated ME]> per min of incubation at 3()OC per mg of protein. /-/"r;;:::""tn/ /;II '" 
exposure time of keratillocytes to 160 nM T PA . Bnrs. SEM (n = ~). 
isofofm of PKC was n ot specified in the ir paper, the antibo d y used 
w as raised against the C2 domain of th e a isoform, a seq uence that 
is homologous only to th e con ven tio nal PKC .isofonns and not to 
the othe.r groups of PKC isoform s. T h us, t h e prese nt observatio n is 
also con sistent with t he work of Fournier an d Murray [24] . 
Observation of T PA-indu ced down-regu lation h ave been re-
ported in conventiona l a and {3, and n ovel a and E PKC isoforms 
but such down- regul atio n was abse n t i.1I atyp ica l S isofonn [25,26]. 
Conflict ing observations have b een reported in dl e li terature 
regarding the 7J isoform : Gschwe n t el al [27] re p orted that t here was 
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F ig u re 5. Confocal laser scanning microscopic observation of the 
.,., isoform (A - D) and the IX isoform (E, F) ill human keralinocytes 
(A , B) and overexpressing COS! cells (C- F). T he ce ll s were treated 
with 160 nM TPA for 0 lIlin ,,~. c.E) and 5 min (B.DY). 
complete down-regulatio n o f the 17 isofo l1n in m o u se skin il t /Iii ,,, 
w he n trea ted w ith TPA or bryosta tin. an 'l c tiva tor ofPKC in m o use 
skin ke ratinoc ytes . D e llnin g ('( aI1 2S], h o w ever , re po rted that t he 17 
isoform was not down-regu late d b y bryos tatin. Similarl y. R.e ynolds 
el al [29.1 fo un d that th e 17 isoform was not down-reg ulated n or 
tran slocated whe n human ke ratin ocytes w e re stim ulated by TPA o r 
bryostatin. 
Amon g the m e mbers of th e PK C family , dl e E iso form sh ows 
hig h homology w ith t he 17 iso to rll1 in th e struc tu res : however. t hese 
twO isofo rms respond diffe rentl y to p h orbo l este rs . The E iso for11l is 
t rans located an d down-reg ulated rapidl y b y pho rbo l esters 
[26,29,30], w he reas th e T) isoform is not. We arc interested in 
tlnd ing a responsible sequen ce. if :ln y, fo r in trace llular loca li z atio n , 
down-regul ation, an d tra ns locatio n. b y the usc o f c him e ri ca l mol-
ecules bct\.veen th ese t\VO iso forn l :-i. 
Castal,"la 1'1 alp 1 o ri g ina ll y reported that PKC acts as a receptor 
fo r tulllo r pro m oters ~ nd is ocrivated by them. PJ( C is gener~ lI y 
th ought to p laya c ru c ial role in t h e promotio n stage . alth o ug h a 
specifi c isofo rl11 in vo lved is n o t we ll und e rstood. We rece ntl y 
d e m o nstrated th m c hole sterol sulfate, ~ n activator of the 17 iso fo rl11 , 
is a pote nt inhibito r in mouse skin c:m :in ogenesi s 13 1]. 
, Vi' ,1,,1/1'" Dr. P. C hall,l!. ./ill' (r;(;(a/ rcar/ill.v. all(/ /\'. T,'/':n; ji)f I(,( /1I1;(n l SII/'POIt. 
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